Elias Fattal Selected Research

Nanocapsules

10/2017	Ultrasound-induced mild hyperthermia improves the anticancer efficacy of both Taxol® and paclitaxel-loaded nanocapsules.
11/2016	Paclitaxel-loaded PEGylated nanocapsules of perfluorooctyl bromide as theranostic agents.
1/2015	Aqueous-core PEG-coated PLA nanocapsules for an efficient entrapment of water soluble anticancer drugs and a smart therapeutic response.
5/2014	RGD decoration of PEGylated polyester nanocapsules of perfluorooctyl bromide for tumor imaging: influence of pre or post-functionalization on capsule morphology.
8/2012	Long-circulating perfluorooctyl bromide nanocapsules for tumor imaging by 19FMRI.
3/2010	The performance of PEGylated nanocapsules of perfluorooctyl bromide as an ultrasound contrast agent.
5/2006	Efficacy of siRNA nanocapsules targeted against the EWS-Fli1 oncogene in Ewing sarcoma.
1/2006	Antisense oligonucleotide nanocapsules efficiently inhibit EWS-Fli1 expression in a Ewing's sarcoma model.
10/2003	Oligonucleotides targeted against a junction oncogene are made efficient by nanotechnologies.
1/2002	Nanocapsule technology: a review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elias Fattal Research Topics

Disease

32	Neoplasms (Cancer) 03/2024 - 01/2002
11	Inflammation (Inflammations) 08/2023 - 07/2007
6	Rheumatoid Arthritis 08/2023 - 01/2019
6	Breast Neoplasms (Breast Cancer) 01/2018 - 02/2005
4	Arthritis (Polyarthritis) 08/2023 - 01/2013
4	Pneumonia (Pneumonitis) 03/2023 - 11/2020
3	Experimental Arthritis 08/2023 - 01/2023
3	Lung Diseases (Lung Disease) 05/2023 - 08/2017
3	Fibrosis (Cirrhosis) 01/2022 - 09/2019
3	Infections 06/2019 - 01/2002
3	Chronic Obstructive Pulmonary Disease (COPD) 03/2019 - 09/2018
3	Adenocarcinoma 01/2019 - 05/2013
3	Necrosis 01/2018 - 03/2015
3	Wounds and Injuries (Trauma) 10/2017 - 02/2015
3	Lung Neoplasms (Lung Cancer) 11/2016 - 06/2009
3	Multiple Myeloma 02/2010 - 02/2005
3	Ewing Sarcoma (Sarcoma, Ewing) 05/2006 - 10/2003
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 07/2021
2	Macular Degeneration (Age-Related Maculopathy) 05/2021 - 11/2006
2	Triple Negative Breast Neoplasms 10/2018 - 01/2018
2	Hyperthermia 10/2017 - 05/2015
2	Hypersensitivity (Allergy) 02/2009 - 08/2002
1	Weight Loss (Weight Reduction) 03/2024
1	Systemic Scleroderma (Systemic Sclerosis) 01/2022
1	Cardiac Arrhythmias (Arrythmia) 12/2021
1	Heart Failure 12/2021
1	Kidney Neoplasms (Kidney Cancer) 10/2021
1	Pain (Aches) 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 09/2019
1	Bronchiolitis Obliterans Syndrome 09/2019
1	Cystic Fibrosis (Mucoviscidosis) 03/2019
1	Vascular Diseases (Vascular Disease) 01/2019
1	Communicable Diseases (Infectious Diseases) 01/2019
1	Cardiotoxicity 01/2019
1	Osteosarcoma (Osteogenic Sarcoma) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019

Drug/Important Bio-Agent (IBA)

19	Liposomes (Liposome)IBA 03/2024 - 02/2005
14	Hyaluronic Acid (Hyaluronan)IBA 12/2022 - 06/2009
11	Small Interfering RNA (siRNA)IBA 01/2023 - 05/2006
10	NanocapsulesIBA 10/2017 - 01/2002
7	CytokinesIBA 03/2023 - 02/2009
6	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2006
5	LipidsIBA 09/2018 - 02/2005
5	Antisense OligonucleotidesIBA 05/2009 - 10/2003
4	Dexamethasone (Maxidex)FDA LinkGeneric 05/2023 - 01/2019
3	ProdrugsIBA 08/2023 - 11/2013
3	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 08/2023 - 02/2005
3	Dendrimers (Dendrons)IBA 01/2023 - 08/2017
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 08/2017
3	CollagenIBA 07/2021 - 10/2017
3	EWS-FLI fusion proteinIBA 05/2006 - 10/2003
2	Phosphorus (Red Phosphorus)IBA 01/2023 - 08/2017
2	Everolimus FDA Link 01/2022 - 07/2021
2	PalmitatesIBA 05/2021 - 01/2019
2	Nucleic AcidsIBA 01/2021 - 01/2020
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2019 - 09/2018
2	EmulsionsIBA 01/2019 - 11/2016
2	LuciferasesIBA 10/2018 - 11/2016
2	UraniumIBA 04/2017 - 06/2015
2	Calixarenes (Calixarene)IBA 04/2017 - 06/2015
2	Messenger RNA (mRNA)IBA 11/2016 - 05/2006
2	Adenosine Triphosphate (ATP)IBA 11/2014 - 03/2013
2	perflubron (L 1913)FDA Link 05/2014 - 08/2012
2	LigandsIBA 11/2013 - 01/2013
2	Gemcitabine FDA Link 11/2013 - 05/2013
1	carbazoleIBA 03/2024
1	Diclofenac (SR 38)FDA LinkGeneric 08/2023
1	AntagomirsIBA 08/2023
1	RNA (Ribonucleic Acid)IBA 08/2023
1	MolybdenumIBA 03/2023
1	Ethylene Glycol (Monoethylene Glycol)IBA 12/2022
1	MucinsIBA 12/2022
1	Sepharose (Agarose)IBA 10/2021
1	SuspensionsIBA 05/2021
1	Poly(amidoamine)IBA 11/2020
1	LipopolysaccharidesIBA 11/2020
1	PAMAM StarburstIBA 11/2020
1	GlucocorticoidsIBA 01/2020
1	Janus Kinase InhibitorsIBA 01/2020
1	Antirheumatic Agents (DMARD)IBA 01/2020
1	AntibodiesIBA 01/2020
1	Methotrexate (Mexate)FDA LinkGeneric 01/2020
1	EchinomycinIBA 09/2019
1	CyclodextrinsIBA 09/2019
1	CyanoacrylatesIBA 06/2019
1	Meloxicam (Mobic)FDA LinkGeneric 03/2019
1	Ethiodized Oil (Ethiodol)FDA Link 01/2019
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2019
1	Ditiocarb (Sodium Diethyldithiocarbamate)FDA Link 01/2019
1	CopperIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 10/2018
1	Rosiglitazone (Avandia)FDA Link 09/2018

Therapy/Procedure

7	Therapeutics 01/2022 - 09/2010
3	Drug Therapy (Chemotherapy) 03/2024 - 01/2015
3	Intravenous Injections 03/2010 - 10/2008
2	Intravitreal Injections 07/2012 - 07/2007
1	Replacement Arthroplasty 01/2019